Scientists are excitedly focused on retatrutide, a novel treatment created by Eli Lilly, as a possible breakthrough in weight management. Unlike many previous approaches, retatrutide is a twin-action compound targeting equally GLP-1 and GIP, substances that affect satiety and blood sugar balance. I